Tudor Investment Corp ET AL Buys Shares of 177,409 Phreesia, Inc. $PHR

Tudor Investment Corp ET AL purchased a new stake in shares of Phreesia, Inc. (NYSE:PHR) during the third quarter, HoldingsChannel.com reports. The fund purchased 177,409 shares of the company’s stock, valued at approximately $4,173,000.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in Phreesia by 8.3% during the third quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company’s stock valued at $134,177,000 after purchasing an additional 437,462 shares during the period. New York State Common Retirement Fund grew its position in Phreesia by 727.1% in the 3rd quarter. New York State Common Retirement Fund now owns 136,856 shares of the company’s stock worth $3,219,000 after purchasing an additional 120,309 shares during the period. Squarepoint Ops LLC raised its stake in Phreesia by 243.6% during the 2nd quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock valued at $2,872,000 after buying an additional 71,553 shares during the last quarter. Greenhouse Funds LLLP raised its stake in Phreesia by 16.8% during the 3rd quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock valued at $91,317,000 after buying an additional 557,265 shares during the last quarter. Finally, Bessemer Group Inc. raised its stake in Phreesia by 1,065.9% during the 3rd quarter. Bessemer Group Inc. now owns 554,513 shares of the company’s stock valued at $13,043,000 after buying an additional 506,954 shares during the last quarter. 92.10% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. DA Davidson dropped their price target on Phreesia from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Friday, January 23rd. Zacks Research cut Phreesia from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 6th. Mizuho lowered their target price on Phreesia from $22.00 to $19.00 and set an “outperform” rating on the stock in a report on Tuesday. JPMorgan Chase & Co. dropped their target price on Phreesia from $29.00 to $24.00 and set an “overweight” rating on the stock in a research report on Friday, February 20th. Finally, Needham & Company LLC restated a “buy” rating and set a $35.00 price target on shares of Phreesia in a research note on Monday, December 8th. Seventeen analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Phreesia has an average rating of “Moderate Buy” and a consensus price target of $28.94.

Phreesia Stock Down 0.3%

PHR opened at $11.24 on Thursday. The firm’s 50 day simple moving average is $12.81 and its two-hundred day simple moving average is $18.05. The company has a market capitalization of $677.84 million, a PE ratio of -112.42 and a beta of 0.67. Phreesia, Inc. has a 1-year low of $10.75 and a 1-year high of $32.76. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.01.

Insider Transactions at Phreesia

In related news, General Counsel Allison C. Hoffman sold 6,176 shares of Phreesia stock in a transaction on Monday, March 23rd. The stock was sold at an average price of $11.97, for a total transaction of $73,926.72. Following the transaction, the general counsel directly owned 163,485 shares in the company, valued at approximately $1,956,915.45. The trade was a 3.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Amy Beth Vanduyn sold 2,202 shares of the company’s stock in a transaction dated Friday, January 16th. The stock was sold at an average price of $16.36, for a total value of $36,024.72. Following the completion of the sale, the senior vice president owned 157,349 shares of the company’s stock, valued at approximately $2,574,229.64. The trade was a 1.38% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 66,529 shares of company stock worth $1,080,454 over the last three months. 5.50% of the stock is currently owned by insiders.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.